Trial Profile
Effect of S1 + Paclitaxel as a second-line therapy in advanced gastric cancer patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 12 Dec 2015 New trial record